Hibrow Hlthcare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HIBROW HLTHCARE, and what generic and branded alternatives to HIBROW HLTHCARE drugs are available?
HIBROW HLTHCARE has six approved drugs.
Drugs and US Patents for Hibrow Hlthcare
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hibrow Hlthcare | POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 214426-003 | Feb 19, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Hibrow Hlthcare | NIACIN | niacin | TABLET, EXTENDED RELEASE;ORAL | 213090-002 | Aug 25, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Hibrow Hlthcare | VALPROIC ACID | valproic acid | CAPSULE;ORAL | 207611-001 | Aug 5, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Hibrow Hlthcare | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 211556-001 | Oct 18, 2019 | BX | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Hibrow Hlthcare | POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 214426-001 | Feb 19, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.